← Back to Search

Dietary Supplement

Fucoidan Supplements for Fatigue in Cancer Survivors

N/A
Waitlist Available
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 16 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to see if taking a supplement called fucoidan for 8 weeks can help cancer patients with fatigue after treatment. Researchers will also look at how fatigue, weakness, and inflammation change

Who is the study for?
This trial is for cancer survivors who are experiencing fatigue after their treatment. Participants should be interested in trying a seaweed supplement called fucoidan for 8 weeks to see if it helps reduce their tiredness and inflammation.
What is being tested?
The study is testing two types of fucoidan supplements, one from U. Pinnatifida seaweed and another from F. Vesiculosus, to evaluate their effectiveness in alleviating post-treatment fatigue and reducing signs of frailty and inflammation in cancer survivors.
What are the potential side effects?
Potential side effects may include digestive discomfort or allergic reactions due to the seaweed origin of the supplements; however, specific side effects related to fucoidan have not been detailed.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 16 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 16 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
mean change in Brief Fatigue Inventory
mean change in frailty using a modified Fried's Frailty questionnaire

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: FucoidanExperimental Treatment1 Intervention
They will receive 4 grams daily of fucoidan extracted from F. Vesiculosus for 8 weeks.
Group II: Usual CareActive Control1 Intervention
They will receive usual care for 8 weeks followed by 4 grams daily of fucoidan extracted from U. Pinnatifida for 8 weeks.

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,928 Previous Clinical Trials
41,018,030 Total Patients Enrolled
University of RochesterLead Sponsor
869 Previous Clinical Trials
549,732 Total Patients Enrolled
~20 spots leftby Apr 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top